Vaccines news rekindles buying interest in pharmaceutical counters
Bernama
February 22, 2021 11:33 MYT
February 22, 2021 11:33 MYT
KUALA LUMPUR: The arrival of the first batch of Pfizer-BioNTech COVID-19 vaccines on Sunday has rekindled buying interest in pharmaceutical counters in the morning session.
At 10.13 am, Pharmaniaga Bhd saw its share rose seven sen to RM4.93 with 517,000 shares traded, while Duopharma Biotech Bhd’s share perked one sen to RM3.49 with 651,200 shares changing hands.
Ho Wah Genting Bhd also increased 2.5 sen to 70.5 sen with 10.21 million shares traded.
However, the vaccine-induced euphoria did not bode well for rubber glove counters.
At 10.13 am, Top Glove Corporation Bhd suffered heavy selling pressure with its share falling 19 sen to RM5.86, with 6.61 million shares transacted.
Similarly, Supermax Corporation Bhd lost 24 sen to RM5.56, with 5.13 million shares traded, while Hartalega Holdings Bhd was four sen lower at RM12.02, with 672,300 shares changing hands.
Rakuten Trade Sdn Bhd believes sentiments will be boosted by news of the COVID-19 vaccine availability.
But performance may be negated as glove counters could see continued selling as a result, it said in a note today.
With the first batch of 312,390 doses of the Pfizer-BioNTech vaccine arriving in the country on Sunday, Malaysia has now joined the global community in a more intense fight against coronavirus.
-- BERNAMA